Clinical and laboratory outcomes during the treatment of rheumatoid arthritis with methotrexate.

Update item information
Publication Type Journal Article
School or College College of Health; School of Medicine
Department Internal Medicine; Physical Therapy
Creator Cannon, Grant W.
Other Author Reading, J.C.; Ward, J.R.; Blonquist, L.J.; Collette, L.B.
Title Clinical and laboratory outcomes during the treatment of rheumatoid arthritis with methotrexate.
Date 1990-02-01
Description Ten clinical and three laboratory outcomes were evaluated in 86 patients completing a double-blind placebo-controlled trial of methotrexate in rheumatoid arthritis. The improvement in all measured outcomes was statistically significantly better in patients receiving methotrexate than in patients receiving placebo. The correlations of the changes in outcome measures were calculated to determine if improvement in one parameter was associated with improvement in other clinical parameters. Associations between different clinical outcomes were often statistically significant. Associations between laboratory outcomes were also often statistically significant. However, the association between clinical outcomes and laboratory outcomes was generally poor.
Type Text
Publisher Taylor & Francis
Volume 19
Issue 4
First Page 285
Last Page 294
Subject C-Reactive Protein; Fluorescent Antibody Technique; Latex Fixation Tests; Randomized Controlled Trials
Subject MESH Arthritis, Rheumatoid; Methotrexate; Edema
Language eng
Bibliographic Citation Scand J Rheumatol. 1990;19(4):285-94. Cannon GW, Reading JC, Ward JR, Blonquist LJ, Collette LB. Clinical and laboratory outcomes during the treatment of rheumatoid arthritis with methotrexate.
Rights Management Copyright © 1990 Taylor & Francis. All rights reserved.
Format Medium application/pdf
Identifier ir-main,820
ARK ark:/87278/s6d22fqg
Setname ir_uspace
Date Created 2012-06-13
Date Modified 2012-06-13
ID 702455
Reference URL https://collections.lib.utah.edu/ark:/87278/s6d22fqg
Back to Search Results